Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Knight

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
BMC Musculoskeletal Disorders|January 22, 2014
Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritisMatthew Richard Cawson, Stephen Andrew Mitchell, Chris Knight, et al.
Nature Communications|January 22, 2015
Discovery of optimal zeolites for challenging separations and chemical transformations using predictive materials modelingPeng Bai, Mi Young Jeon, Limin Ren, et al.
ACS Central Science|July 15, 2016
First-Principles Monte Carlo Simulations of Reaction Equilibria in Compressed VaporsEvgenii O Fetisov, I-Feng William Kuo, Chris Knight, et al.
Osteoarthritis and Cartilage Open|September 17, 2024
Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD studyFelix Eckstein, Susanne Maschek, Wolfgang Wirth, et al.
Pharmacoeconomics|November 25, 2020
Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid LeukemiaCarla Mamolo, Verna Welch, Roland B Walter, et al.
Osteoarthritis and Cartilage|June 6, 2024
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?Felix Eckstein, Anna Wisser, Susanne Maschek, et al.
BMJ Open|September 18, 2014
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov modelPhilippe Laramée, Thor-Henrik Brodtkorb, Nora Rahhali, et al.
Osteoarthritis and Cartilage|December 29, 2024
Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trialPhilip G Conaghan, Nathaniel Katz, David J Hunter, et al.
The Journal of Chemical Physics|November 24, 2016
On the accuracy of the MB-pol many-body potential for water: Interaction energies, vibrational frequencies, and classical thermodynamic and dynamical properties from clusters to liquid water and iceSandeep K Reddy, Shelby C Straight, Pushp Bajaj, et al.
Journal of Comparative Effectiveness Research|July 7, 2022
The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK settingZalmai Hakimi, Koo Wilson, Eoin McAughey, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
BMC Musculoskeletal Disorders|January 22, 2014
Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritisMatthew Richard Cawson, Stephen Andrew Mitchell, Chris Knight, et al.
Nature Communications|January 22, 2015
Discovery of optimal zeolites for challenging separations and chemical transformations using predictive materials modelingPeng Bai, Mi Young Jeon, Limin Ren, et al.
ACS Central Science|July 15, 2016
First-Principles Monte Carlo Simulations of Reaction Equilibria in Compressed VaporsEvgenii O Fetisov, I-Feng William Kuo, Chris Knight, et al.
Osteoarthritis and Cartilage Open|September 17, 2024
Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD studyFelix Eckstein, Susanne Maschek, Wolfgang Wirth, et al.
Pharmacoeconomics|November 25, 2020
Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid LeukemiaCarla Mamolo, Verna Welch, Roland B Walter, et al.
Osteoarthritis and Cartilage|June 6, 2024
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?Felix Eckstein, Anna Wisser, Susanne Maschek, et al.
BMJ Open|September 18, 2014
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov modelPhilippe Laramée, Thor-Henrik Brodtkorb, Nora Rahhali, et al.
Osteoarthritis and Cartilage|December 29, 2024
Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trialPhilip G Conaghan, Nathaniel Katz, David J Hunter, et al.
The Journal of Chemical Physics|November 24, 2016
On the accuracy of the MB-pol many-body potential for water: Interaction energies, vibrational frequencies, and classical thermodynamic and dynamical properties from clusters to liquid water and iceSandeep K Reddy, Shelby C Straight, Pushp Bajaj, et al.
Journal of Comparative Effectiveness Research|July 7, 2022
The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK settingZalmai Hakimi, Koo Wilson, Eoin McAughey, et al.
Pageof 4